Alhabeeb Waleed, Tash Adel A, Alshamiri Mostafa, Arafa Mohamed, Balghith Mohammed A, ALmasood Ali, Eltayeb Abdulla, Elghetany Hossam, Hassan Taher, Alshemmari Owayed
Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
Consultant Cardiac Surgeon, Adult Cardiac Surgery, Ministry of Health, Saudi Arabia.
J Saudi Heart Assoc. 2023 Mar 3;35(1):16-39. doi: 10.37616/2212-5043.1328. eCollection 2023.
Hypertension is a highly prevalent disease in Saudi Arabia with poor control rates. Updated guidelines are needed to guide the management of hypertension and improve treatment outcomes.
A panel of experts representing the National Heart Center (NHC) and the Saudi Heart Association (SHA) reviewed existing evidence and formulated guidance relevant to the local population, clinical practice and the healthcare system. The recommendations were reviewed to ensure scientific and medical accuracy.
Hypertension was defined and a new classification was proposed as relevant to the Saudi population. Recommendations on diagnosis, clinical evaluation, cardiovascular assessment were detailed, along with guidance on measurement modalities and screening/follow-up. Non-pharmacological management is the first line of hypertension treatment. Pharmacological therapy should be used appropriately as needed. Treatment priority is to control blood pressure regardless of the drug class used. The choice of treatment should be tailored to the patient profile in order to achieve treatment targets and ensure patient compliance. Recommendations were provided on pharmacological options available in Saudi Arabia, as well as guidance on the treatment of special conditions.
Hypertension management should be based on appropriate screening, timely diagnosis and lifestyle changes supplemented with pharmacological therapy, as needed. Clinical management should be individualized, and careful consideration should be given to special conditions and patient groups.
高血压在沙特阿拉伯是一种高度流行的疾病，控制率较低。需要更新指南来指导高血压的管理并改善治疗效果。
一个由代表国家心脏中心（NHC）和沙特心脏协会（SHA）的专家组成的小组审查了现有证据，并制定了与当地人群、临床实践和医疗保健系统相关的指南。对这些建议进行了审查以确保科学和医学准确性。
对高血压进行了定义，并提出了一种与沙特人群相关的新分类。详细阐述了关于诊断、临床评估、心血管评估的建议，以及测量方式和筛查/随访的指导。非药物治疗是高血压治疗的第一线。应根据需要适当使用药物治疗。治疗的首要任务是控制血压，无论使用何种药物类别。治疗选择应根据患者情况进行调整，以实现治疗目标并确保患者依从性。提供了关于沙特阿拉伯可用药物选择的建议，以及特殊情况治疗的指导。
高血压管理应基于适当的筛查、及时诊断和生活方式改变，并根据需要辅以药物治疗。临床管理应个体化，并应仔细考虑特殊情况和患者群体。
